These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 39263021)
1. Neutrophil estimation and prognosis analysis based on existing lung squamous cell carcinoma datasets: the development and validation of a prognosis prediction model. Wang Y; Li D; Li Q; Basnet A; Efird JT; Seki N Transl Lung Cancer Res; 2024 Aug; 13(8):2023-2037. PubMed ID: 39263021 [TBL] [Abstract][Full Text] [Related]
2. Significance of Lin H; Wang J; Shi Q; Wu M PeerJ; 2024; 12():e17338. PubMed ID: 38708353 [TBL] [Abstract][Full Text] [Related]
3. Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing. Yang L; Wei S; Zhang J; Hu Q; Hu W; Cao M; Zhang L; Wang Y; Wang P; Wang K J Transl Med; 2022 Aug; 20(1):364. PubMed ID: 35962453 [TBL] [Abstract][Full Text] [Related]
4. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C Front Immunol; 2023; 14():1236444. PubMed ID: 37841237 [TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a tumor mutational burden and immune-related prognostic model for predicting the prognosis of patients with lung squamous cell carcinoma. Zhou Y; Xu M; Zhao K; Liu B J Thorac Dis; 2023 Mar; 15(3):1319-1334. PubMed ID: 37065576 [TBL] [Abstract][Full Text] [Related]
6. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Yang Q; Gong H; Liu J; Ye M; Zou W; Li H Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696 [TBL] [Abstract][Full Text] [Related]
7. Prediction of immune subtypes and overall survival in lung squamous cell carcinoma. Su X; Gao H; Qi Z; Xu T; Wang G; Luo H; Cheng P Curr Med Res Opin; 2023 Feb; 39(2):289-298. PubMed ID: 36245361 [TBL] [Abstract][Full Text] [Related]
8. An investigation to identify tumor microenvironment-related genes of prognostic value in lung squamous cell carcinoma based on The Cancer Genome Atlas. Liu H; Liu B; Zhang L; Li M; Chen C; He S; Luo T; He X; Tan L Transl Cancer Res; 2021 Apr; 10(4):1885-1899. PubMed ID: 35116510 [TBL] [Abstract][Full Text] [Related]
9. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach. Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
11. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach. Yang J; Ouedraogo SY; Wang J; Li Z; Feng X; Ye Z; Zheng S; Li N; Zhan X EPMA J; 2024 Mar; 15(1):67-97. PubMed ID: 38463626 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma. Wang Q; Chen Y; Gao W; Feng H; Zhang B; Wang H; Lu H; Tan Y; Dong Y; Xu M Front Oncol; 2022; 12():933925. PubMed ID: 35912252 [TBL] [Abstract][Full Text] [Related]
13. Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I-III lung squamous cell carcinoma. Lai J; Yang S; Chu S; Xu T; Huang J Front Genet; 2022; 13():921837. PubMed ID: 36118890 [No Abstract] [Full Text] [Related]
14. Systematic analysis of apoptosis-related genes in the prognosis of lung squamous cell carcinoma: a combined single-cell RNA sequencing study. Zhu P; Yang W; Wang B; Zeng T; Hu Z; Zhang D; Yang Z; Wang K; Pu J J Thorac Dis; 2023 Dec; 15(12):6946-6966. PubMed ID: 38249925 [TBL] [Abstract][Full Text] [Related]
15. A novel model based on liquid-liquid phase separation-Related genes correlates immune microenvironment profiles and predicts prognosis of lung squamous cell carcinoma. Zhuge L; Zhang K; Zhang Z; Guo W; Li Y; Bao Q J Clin Lab Anal; 2022 Jan; 36(1):e24135. PubMed ID: 34799879 [TBL] [Abstract][Full Text] [Related]
16. A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma. Li X; He J Int J Gen Med; 2021; 14():6439-6453. PubMed ID: 34675612 [TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma. Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
19. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
20. The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma. Huang H; Wu W; Lu Y; Pan X J Thorac Dis; 2022 Oct; 14(10):4055-4072. PubMed ID: 36389308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]